Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

4.020 +0.030 (+0.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Geron Corp

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Geron (GERN) Q4 2022 Earnings Call Transcript
GERN earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones
From Geron Corporation
Via Business Wire
Earnings Outlook For Geron
Via Benzinga
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023
From Geron Corporation
Via Business Wire
2 Top Healthcare Stocks to Buy Right Now
One has a breakout drug, the other a nice-sized moat. 
Via The Motley Fool
Why Geron Stock Is Falling After Hours
Geron Corp (NASDAQ: GERN) shares are trading lower in Wednesday's after-hours session after the company announced a  
Via Benzinga
SMID Cap Life Science Update: Are You An Investor Or Trader?
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
Via Talk Markets
7 A-Rated Penny Stocks Worth Betting On
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance. 
Via InvestorPlace
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. 
Via InvestorPlace
7 A-Rated Stocks to Buy for February 2023
Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader. 
Via InvestorPlace
Why Is Geron (GERN) Stock Soaring 50% Today?
Late-stage clinical biopharma Geron delivered positive results for its blood cancer therapeutic, dramatically lifting GERN stock. 
Via InvestorPlace
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
7 A-Rated Stocks to Buy for Less Than $25
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market. 
Via InvestorPlace
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference
From Geron Corporation
Via Business Wire
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
From Geron Corporation
Via Business Wire
Geron Corporation Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Plus Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $227.8 Million
From Geron Corporation
Via Business Wire
Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Geron Corporation
Via Business Wire
Exclusive: 5 Stocks To Watch From Benzinga Moneymaker Index, One Large Cap And 4 Small Cap Names
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. 
Via Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
Constellation Brands, Walgreens, RPM International And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Gainers Vyant Bio, Inc. (NASDAQ: VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Geron Corporation Announces Proposed Public Offering of Common Stock
From Geron Corporation
Via Business Wire
Dow Gains 150 Points After Fed Minutes
U.S. stocks traded higher toward the end of trading, following the release of minutes from the FOMC meeting. 
Via Benzinga
Micron News: Why Is MU Stock Up Today?
Micron (MU) stock is on the move Wednesday as one analyst believes the memory market will start to recover in the second half of 2023. 
Via InvestorPlace
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive... 
Via Benzinga
Geron (NASDAQ: GERN) Reports Positive Results From IMerge Phase 3 Trial of Imetelstat for Lower Risk MDS
Geron Corporation (NASDAQ: GERN) is engaged as a late-stage biopharmaceutical company, which is focused on the research and development of 
Via Spotlight Growth
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.